Evidence map›Paper›PMID 31149097›Full record

ArticleActa endocrinologica (Bucharest, Romania : 2005)

C Ştefănescu, L Ionescu, R Dănilă, D Butcovan, R Tibu, S Bilha, D Timofte, C Vulpoi

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta endocrinologica (Bucharest, Romania : 2005). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

C Ştefănescu"Gr. T. Popa" University of Medicine and Pharmacy, Dept. of Biophysics and Medical Physics, Nuclear Medicine, Iasi, Romania.
L Ionescu"Gr. T. Popa" University of Medicine and Pharmacy, Dept. of Surgery, Iasi, Romania.
R Dănilă"Gr. T. Popa" University of Medicine and Pharmacy, Dept. of Surgery, Iasi, Romania.
D Butcovan"Gr. T. Popa" University of Medicine and Pharmacy, Dept. of Histopathology, Iasi, Romania.
R Tibu"Gr. T. Popa" University of Medicine and Pharmacy, Dept. of Endocrinology, Iasi, Romania.
S Bilha"Gr. T. Popa" University of Medicine and Pharmacy, Dept. of Biophysics and Medical Physics, Nuclear Medicine, Iasi, Romania.
D Timofte"Gr. T. Popa" University of Medicine and Pharmacy, Dept. of Surgery, Iasi, Romania.
C Vulpoi"Gr. T. Popa" University of Medicine and Pharmacy, Dept. of Endocrinology, Iasi, Romania.
Active Medicine (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextDespite CT being generally used in thymic pathology, in the case of regions with the same tissue density, only functional radioisotopic imaging can hint towards malignity.

objectivesTo assess the usefulness of PATIENTS AND

methods

resultsThe UR of all surgical patients was higher than 1.2, with a 1.5 cutoff between lymphoid hyperplasia and thymoma. The UR values were correlated with the histopathologic diagnosis (Pearson correlation 0.91, significant at p<0.01). The highest UR was 3.24, found in the case of an AB thymoma where the rate lymphocytes/epithelial cells (L/E) was 1.6. In B1 thymoma UR was 1.14 and L/E was 2.46.

conclusionPhenotype differences between thymoma types correlate with

Indexed as

99mTc MIBI scanRadiotracer Uptake MechanismThymic HyperplasiaThymoma

Identifiers

PMID31149097
PMCPMC6535270
OpenAlexW2529984435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.